HomeIMNM • NASDAQ
Immunome Inc
add
$9.77
4.05%
After Hours:(1.94%)+0.19
$9.96
Closed: Sep 22, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 4.02M | 69.84% |
Operating expense | 48.26M | 37.81% |
Net income | -43.40M | -20.14% |
Net profit margin | -1.08K | 29.26% |
Earnings per share | -0.50 | 16.67% |
EBITDA | -45.84M | -38.29% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 268.04M | -3.71% |
Total assets | 296.29M | 0.03% |
Total liabilities | 27.02M | -36.24% |
Total equity | 269.27M | — |
Shares outstanding | 87.05M | — |
Price to book | 3.04 | — |
Return on assets | -36.37% | — |
Return on capital | -39.70% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -43.40M | -20.14% |
Cash from operations | -49.40M | -111.14% |
Cash from investing | -64.17M | 21.44% |
Cash from financing | -55.00K | -107.93% |
Net change in cash | -113.63M | -8.85% |
Free cash flow | -35.39M | -84.20% |
Previous close
$9.39
Day range
$9.36 - $10.03
Year range
$5.15 - $15.39
Market cap
850.43M USD
Avg Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2006
Headquarters
Website
Employees
155
